Complete pathological response of bone metastasis in metastatic renal cell carcinoma treated with pembrolizumab plus lenvatinib after surgical debulking and palliative radiotherapy: a case report
The case of a 33-year-old female patient with clear cell mRCC who developed metastatic progression after undergoing curative-intent surgery, presenting with vertebral bone metastasis at C7 and peritoneal carcinomatosis is reported.